Immunohistochemical Study Using Monoclonal VE1 Antibody Can Substitute the Molecular Tests for Apprehension of BRAF V600E Mutation in Patients with Non-small-Cell Lung Carcinoma

Table 2

Clinicopathological characteristics of patients with mutant BRAF V600E tumors ().

Patient	BRAF mutation	IHC VE1	IHC intensity scoring	Age	Sex	Histological type	Differentiation
1	Positive	Positive	+3	61	M	Adeno Ca	Poorly diff.
2	Positive	Positive	+1	65	F	Adeno Ca	Poorly diff.
3	Positive	Negative	Zero	62	M	Squamous Ca	Moderate diff.
4	Positive	Positive	+2	59	M	Adeno Ca	Poorly diff.
5	Positive	Positive	+1	67	F	Adeno Ca	Moderate diff.

F, female; M, male; adeno Ca, adenocarcinoma; squamous Ca, squamous carcinoma; diff, differentiated.